Bone Biologics Corp. -CW26BBLGWPreferred / convertible
13F holders, Q1 2026 (March 31)2holders
0new positions
0sold out
1famous investor
$22.86avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding Bone Biologics Corp. -CW26 (BBLGW) in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($684K) and UBS Group AG ($6K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bone Biologics Corp. -CW26
- CUSIP
- 098070154
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 122 shares bought and 5,571 shares sold, net −5,449 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Citadel Advisors | — | Reduce -15.8% | 29,752 | $684K |
| UBS Group AG | — | Add +40.7% | 422 | $6K |
"% of holder's portfolio" is BBLGW's weight in each manager's 13F, not the share of Bone Biologics Corp. -CW26 the manager owns.